Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AN2728 (crisaborole) in mild to moderate atopic dermatitis
NCT02118766Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2014
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
A Phase 3 trial of AN2728 ointment vehicle in atopic dermatitis (AD), sponsored by Pfizer. Started Mar 2014; status: completed.
02
Drugs
AN2728 ointment vehicle
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02118766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118766.